136 related articles for article (PubMed ID: 10679911)
41. Molecular cytogenetic analysis of clustered sporadic and familial renal cell carcinoma-associated 3q13 approximately q22 breakpoints.
Bodmer D; Janssen I; Jonkers Y; van den Berg E; Dijkhuizen T; Debiec-Rychter M; Schoenmakers E; van Kessel AG
Cancer Genet Cytogenet; 2002 Jul; 136(2):95-100. PubMed ID: 12237231
[TBL] [Abstract][Full Text] [Related]
42. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
[TBL] [Abstract][Full Text] [Related]
43. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
44. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
[TBL] [Abstract][Full Text] [Related]
46. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study.
Secker-Walker LM; Mehta A; Bain B
Br J Haematol; 1995 Oct; 91(2):490-501. PubMed ID: 8547101
[TBL] [Abstract][Full Text] [Related]
47. A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia.
Specchia G; Cuneo A; Liso V; Contino R; Pastore D; Gentile E; Rocchi M; Castoldi GL
Br J Haematol; 1999 Apr; 105(1):208-14. PubMed ID: 10233385
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
[TBL] [Abstract][Full Text] [Related]
49. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
[TBL] [Abstract][Full Text] [Related]
50. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
51. Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements.
Ballif BC; Wakui K; Gajecka M; Shaffer LG
Hum Genet; 2004 Jan; 114(2):198-206. PubMed ID: 14579147
[TBL] [Abstract][Full Text] [Related]
52. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
53. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
[TBL] [Abstract][Full Text] [Related]
54. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.
Johansson B; Brøndum-Nielsen K; Billström R; Schiødt I; Mitelman F
Cancer Genet Cytogenet; 1997 Dec; 99(2):97-101. PubMed ID: 9398862
[TBL] [Abstract][Full Text] [Related]
55. Novel constitutional translocations t(3;5)(p25;q22) and t(1;14)(p31;q21) in patients with acute leukemia.
Panani AD; Pappa V; Raptis SA
Ann Hematol; 2004 Mar; 83(3):156-9. PubMed ID: 15064864
[TBL] [Abstract][Full Text] [Related]
56. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
57. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
[TBL] [Abstract][Full Text] [Related]
58. The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML.
Haferlach C; Bacher U; Haferlach T; Dicker F; Alpermann T; Kern W; Schnittger S
Leukemia; 2011 May; 25(5):874-7. PubMed ID: 21283084
[No Abstract] [Full Text] [Related]
59. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
[TBL] [Abstract][Full Text] [Related]
60. Trisomy 11 and a complex t(11;11;22) in a patient with acute myelomonocytic leukemia (AML-M4) following myelodysplasia (MDS): a cytogenetic study of a mechanism of leukemogenesis.
Bernasconi P; Cavigliano PM; Boni M; Malcovati L; Astori C; Castagnola C; Pagnucco G; Vanelli L; Calatroni S; Caresana M; Lazzarino M; Bernasconi C
Cancer Genet Cytogenet; 2000 Jan; 116(2):111-8. PubMed ID: 10640142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
